Investor Relations

Contact Us

Corporate Contact Investor Relations Human Resources General Inquiries

NGS
The dawn of a new age
Read story
MICROBIOME RESEARCH
Behavior - it's all in our gut
Read Interview
TUBERCULOSIS
"Our goal is to develop easy and quick tests"
Read Interview
Tuberculosis
Fighting a common and persistent killer
Read Story

Latest press releases

SUBSCRIBE TO RSS-FEED

11.07.2018
QIAGEN partners with U.K. to expand biomarker research in Manchester
READ MORE
25.06.2018
QIAGEN announces broadening of GeneReader NGS System applications into hereditary disease analysis
READ MORE
07.06.2018
QIAGEN launches new QIAseq 16S Panels and UCP Multiplex PCR kit enabling unbiased microbiome profiling
READ MORE
04.06.2018
QIAGEN welcomes new guidelines from American Academy of Pediatrics for detecting tuberculosis infection in children
READ MORE
31.05.2018
QIAGEN showcases innovation in NGS solutions for precision medicine at ASCO 2018
READ MORE
23.05.2018
QIAGEN launches the DNeasy PowerSoil Pro Kit to advance microbiome characterization in soils
READ MORE
22.05.2018
QIAGEN welcomes WHO’s Essential Diagnostics List which includes QuantiFERON-TB Gold
READ MORE
15.05.2018
Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052/ Share Repurchase
READ MORE
02.05.2018
QIAGEN reports results for first quarter 2018
READ MORE
20.04.2018
QIAGEN announces FDA approval of PartoSure
READ MORE

SEE ALL RELEASES

At a glance

Key figures teaser

Key figures

Strategy teaser

Strategy

IR - Share data teaser

Share data

Shareholder structure

Corporate calendar

SEE ALL EVENTS

Financial reports

SEE ALL REPORTS

Our social media channels

Visit our Social Hub

Do you have further questions?

SOCIAL SHARING

LANGUAGE

OTHER WEBSITES

© QIAGEN 2013 - 18. All rights reserved